Senior regulatory experts from across the medical technology sector will gather in Dubai as the Middle East and African region strengthens its position in global healthcare innovation. In their first joint initiative, Mecomed and the Regulatory Affairs Professionals Society (RAPS) have announced the 2025 MEA MedTech Regulatory Summit, addressing critical challenges in medical device regulation. The summit, set for 30 January 2025 at voco Dubai, comes as regulatory systems worldwide adapt to match the pace of technological advancement.
The one-day summit aims to address crucial challenges facing the medical device industry, with particular emphasis on the impact of artificial intelligence and software on regulatory operations. The programme will explore regulatory developments across the Middle East, Africa, Europe and North America, offering attendees insights into evolving global regulatory strategies.
Mecomed’s Chief Executive Officer, Rami Rajab, highlighted the region’s growing significance: “The Middle East and Africa encompass a growing and diverse MedTech hub in the regulatory community, with rapidly expanding new business opportunities.” He emphasised that as companies extend their global reach, there is an increased demand for educational resources and professional development to support growth whilst advancing patient care.
Professional development meets strategic imperatives
The summit’s timing coincides with a period of rapid transformation in medical device regulation. RAPS Executive Director Bill McMoil reinforced the event’s strategic importance: “Together, we hope to curate an event that stimulates innovation and solutions for transformation across the region.”
The planning committee comprises notable industry figures, including representatives from Boston Scientific Middle East, Edwards Life Sciences, Johnson & Johnson, and BSI, ensuring comprehensive coverage of regulatory challenges and opportunities.
The summit represents a significant step in addressing the complex regulatory requirements facing medical device manufacturers and distributors in the MEA region. It particularly focuses on regulatory reliance implementation, a crucial aspect for companies navigating multiple jurisdictional requirements.
This collaborative initiative between Mecomed, representing medical devices, imaging and diagnostics manufacturers across the Middle East and Africa, and RAPS, the largest global organisation of healthcare product regulatory professionals, demonstrates the industry’s commitment to advancing regulatory excellence in the region.
The complete programme agenda and speaker lineup are expected to be announced in the coming weeks, with registration currently open for interested participants.
- To learn more, visit www.meamedtech.org
